Skip to content

Creatine Supplementation and Cognitive and Physical Tests

The Effect of Creatine Supplementation on Cognitive and Physical Tests

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03352128
Acronym
CREA
Enrollment
14
Registered
2017-11-24
Start date
2018-09-10
Completion date
2019-03-28
Last updated
2019-10-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Creatine Supplementation, Healthy

Brief summary

To assess whether brain creatine availability has an effect on cognition. To do so we will seek to increase brain creatine concentration via a creatine supplementation protocol.

Interventions

DIETARY_SUPPLEMENTCreatine

Participants will have to supplement themselves with creatine for 7 days (20g/day).

DIETARY_SUPPLEMENTCalcium lactate

Participants will have to supplement themselves with calcium lactate for 7 days (elemental calcium: 0.780g/day).

Sponsors

Vrije Universiteit Brussel
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
BASIC_SCIENCE
Masking
TRIPLE (Subject, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 35 Years
Healthy volunteers
Yes

Inclusion criteria

* Healthy (No neurological illness including cardiovascular, renal, and endocrine disorder) * Male/female * No medication / supplements * Non-smoker * Low to moderately active * Between 18 and 35 years old

Exclusion criteria

* Injuries * Illness * Use of medication * Use of creatine in the last 3 months * History of head trauma or seizure * Vegetarian diet \[24\] * Not being able to follow up the restrictions and prohibitions for the subjects (see Restrictions and prohibitions for the subjects)

Design outcomes

Primary

MeasureTime frameDescription
Cognitive performance - change in accuracy (%) during a 90-min cognitive task (i.e. Stroop task)During both lab visits (i.e. after both 7-day supplementation protocols); Accuracy (%) will be assessed during both lab visits with a 90-min cognitive task; Accuracy during the 90-min task will be reported as mean accuracy during 8 blocks of 11min15secAccuracy (in %) will be assessed during a cognitive task, this cognitive task will be completed after both 7-day supplementation protocols (i.e. placebo and creatine)
Cognitive performance - change in reaction time (milliseconds) during a 90-min cognitive task (i.e. Stroop task)During both lab visits (i.e. after both 7-day supplementation protocols); Reaction time (RT) will be assessed during both lab visits with a 90-min cognitive task; RT during the 90-min task will be reported as mean RT during 8 blocks of 11min15secReaction time (in milliseconds) will be assessed during a cognitive task, this cognitive task will be completed after both 7-day supplementation protocols (i.e. placebo and creatine)

Secondary

MeasureTime frameDescription
Physical performance - reaction time (milliseconds) during a 7-min visuomotor reaction time taskDuring both lab visits (i.e. after both 7-day supplementation protocols); visuomotor reaction time will be assessed during both lab visits with a 7-min visuomotor reaction time task.Reaction time (in milliseconds) will be assessed during a visuomotor reaction time task, this physical task will be completed after both 7-day supplementation protocols (i.e. placebo and creatine)

Countries

Belgium

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026